03:28 PM EST - Acasti Pharma Inc. : Announced that the company will present at two upcoming industry conferences, one on June 14, the other on June 19. CEO Jan D'Alvise will provide a corporate overview and discuss its Phase 3-ready therapeutic, CaPre, at the BIO International Convention partnering forum. In addition, Laurent Harvey will present the results of the CaPre Phase 1 and Phase 2 studies at the International Academy of Cardiology Annual Scientific Sessions. Acasti Pharma Inc.
shares V.ACST are trading down $0.01 at $1.70.
